📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-EarningsRead more

J&J CEO to testify at trial for first time on Baby Powder risks

Published 01/27/2020, 10:37 AM
J&J CEO to testify at trial for first time on Baby Powder risks

By Michael Erman and Lisa Girion

NEW BRUNSWICK, N.J. (Reuters) - Johnson & Johnson Chief Executive Officer Alex Gorsky was set to be called as a witness on Monday in what would be his first appearance in a jury trial over allegations that the company's Baby Powder causes cancer.

Lawyers for three men and one woman who sued J&J subpoenaed Gorsky in a trial playing out in a state courtroom in New Brunswick, New Jersey near the company's headquarters.

All four have mesothelioma, a rare and incurable cancer that they said was caused by their exposure to asbestos in Baby Powder applied when they were diapered as infants.

During an earlier phase of the trial, the jury held J&J liable for the plaintiffs' cancers and awarded them $37.2 million in compensation. Now their lawyers are seeking to persuade a second jury that J&J's behavior was so reckless that punitive damages are warranted.

J&J fought the subpoena of Gorsky, arguing that he had no first-hand knowledge about the safety of its powders and that the case involves corporate conduct that occurred long before he joined the company in 2012. Compelling his testimony, J&J said in a motion, would set a precedent that could result in other chief executives being hauled to court and "would serve no purpose other than to harass Mr. Gorsky and divert him from his executive responsibilities."

Last week, the New Jersey Supreme Court turned down the company's request to suspend the subpoena, clearing the way for Gorsky to be called to testify.

The stakes are high. J&J faces more than 16,000 lawsuits. They assert that J&J sold powders contaminated with asbestos, a known carcinogen, and failed to warn users. J&J also faces a federal criminal investigation into how forthright it has been about the products' safety.

In October, J&J disclosed that a contract lab for the U.S. Food and Drug Administration had found asbestos in a bottle of Baby Powder produced in 2018. The company questioned the finding and commissioned tests on samples from the same bottle and talc from the same lot. Less than two weeks later, J&J announced those tests had found no contamination, other than some asbestos it attributed to an air conditioner in the lab.

In December 2018, a Reuters report based on J&J documents produced in litigation showed that the company knew small amounts of asbestos had been found in its talc on occasion since 1971. J&J dismissed the Reuters' report as "an absurd conspiracy theory."

Gorsky's road to court began in the days following the publication of that report when he took the lead in company efforts to rebut it. The chief executive attested to the safety and purity of Johnson's Baby Powder in a video posted on the company's website and in an appearance on CNBC's "Mad Money." 

"We unequivocally believe that our talc, our Baby Powder, does not contain asbestos," Gorsky told the investment show's host Jim Cramer.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.